Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Aventis Pharmaceuticals Inc.
Current Parent Company: Sanofi
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Recap of Ownership Changes:  subscribe to see this data field
Penalty: $40,000,000
Year: 2003
Date: January 27, 2003
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Secondary Offense: generic drug pay for delay
Mega-Scandal: Generic Drug Pay for Delay
Violation Description: Aventis Pharmaceuticals Inc. and Andrx Corporation agreed to pay a total of $80 million to settle multistate antitrust litigation alleging they conspired to keep a popular generic heart medication off the market. The division of the costs between the two companies was not disclosed; here we assume the amount was divided equally between the two.
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: France
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Link to Archived Court Document:  subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.